e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Airway cell biology and immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab
M. Roth, M. Tamm (Basel, Switzerland)
Source:
Annual Congress 2008 - Airway cell biology and immunology
Session:
Airway cell biology and immunology
Session type:
Thematic Poster Session
Number:
3591
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Roth, M. Tamm (Basel, Switzerland). Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab. Eur Respir J 2008; 32: Suppl. 52, 3591
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Omalizumab inhibits IgE-induced extracellular matrix deposition by asthmatic airway smooth muscle cells
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011
IgE-induced pro-inflammatory extracellular matrix composition in airway smooth muscle cells is prevented by omalizumab
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Tocotrienol inhibits TGF-beta1-induced human airway smooth muscle cell differentiation
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004
The effect of gamma-tocotrienol on human airway smooth muscle cell proliferation and migration
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Mast cell regulation of airway smooth muscle function in asthma
Source: Eur Respir J 2007; 29: 827-830
Year: 2007
Upregulation of airway smooth muscle (ASM) cell apoptosis may limit ASM growth during airway remodeling in experimental asthma
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
Mechanisms of airway smooth muscle reactivity in an allergen-induced asthmatic reaction in rats
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Role of apoptosis in airway smooth muscle remodeling in experimental asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 369s
Year: 2007
MNK-1 inhibition reduces proliferation and CXCL10 in airway smooth muscle cells
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Pharmacology of airway smooth muscle and cell influx in a murine asthma model
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
Mevastatin ameliorates sphingosine 1-phosphate-induced inflammation in human tracheal smooth muscle cells
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
A comparison of beta
2
-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Mechanisms of bronchial hyperresponsiveness in a clinical setting – putative role of smooth muscle
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Increased activation of TGF-β by asthmatic airway smooth muscle cells via integrin αVβ5
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Formoterol reduces asthmatic airway smooth muscle cell proliferation through p27 (Kip) which is supported by steroids
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Eosinophil-induced airway smooth muscle cells remodeling is attenuated by blocking of RGD-binding integrins in asthma
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept